Related references
Note: Only part of the references are listed.Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
John Pernow et al.
CARDIOVASCULAR RESEARCH (2013)
Effects of fisetin supplementation on hepatic lipogenesis and glucose metabolism in Sprague-Dawley rats fed on a high fat diet
Yoonsu Cho et al.
FOOD CHEMISTRY (2013)
Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus
Alexey Shemyakin et al.
CIRCULATION (2012)
Overexpression of Endothelial Nitric Oxide Synthase Prevents Diet-Induced Obesity and Regulates Adipocyte Phenotype
Brian E. Sansbury et al.
CIRCULATION RESEARCH (2012)
Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice
Jiansheng Huang et al.
FASEB JOURNAL (2012)
Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity
Oh Yoen Kim et al.
NUTRITION (2012)
Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis
Yoo Jeong Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats
Julia Gronros et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
Eva Moran-Salvador et al.
FASEB JOURNAL (2011)
Beneficial effects of l-arginine on reducing obesity: potential mechanisms and important implications for human health
Jason R. McKnight et al.
AMINO ACIDS (2010)
Cevoglitazar, a Novel Peroxisome Proliferator-Activated Receptor-α/γ Dual Agonist, Potently Reduces Food Intake and Body Weight in Obese Mice and Cynomolgus Monkeys
Hong Chen et al.
ENDOCRINOLOGY (2010)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes
G. K. McConell et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Nitric oxide and AMPK cooperatively regulate PGC-1α in skeletal muscle cells
Vitor A. Lira et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
High fat feeding and dietary l-arginine supplementation differentially regulate gene expression in rat white adipose tissue
Wenjuan Jobgen et al.
AMINO ACIDS (2009)
Arginine and arginase - Endothelial NO synthase double crossed?
Paul M. Vanhoutte
CIRCULATION RESEARCH (2008)
Diabetes-induced coronary vascular dysfunction involves increased arginase activity
Maritza J. Romero et al.
CIRCULATION RESEARCH (2008)
Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism
Matthew T. Flowers et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice
C. Bonnard et al.
DIABETES & METABOLISM (2008)
Role of adipocytokines in obesity-associated insulin resistance
Chenhui Zou et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes - A time-course and dose-response study
Apiradee Sriwijitkamol et al.
DIABETES (2007)
Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance
Claudia R. Vianna et al.
CELL METABOLISM (2006)
AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress
Yingjia Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Knockdown of arginase I restores NO signaling in the vasculature of old rats
AR White et al.
HYPERTENSION (2006)
Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates
Wenjuan Shi Jobgen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2006)
AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle
AC Smith et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
SE Schadinger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2004)
Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model
S Kim et al.
GENE (2004)
Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles
CH Zhang et al.
HYPERTENSION (2004)
Be fit or be sick: Peroxisome proliferator-activated receptors are down the road
B Desvergne et al.
MOLECULAR ENDOCRINOLOGY (2004)
Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction
TJ Bivalacqua et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
JJ Lehman et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
